BAYER DIAGNOSTICS ACS:180 AND ADVIA CENTAUR ANTI-TPO ASSAY

System, Test, Thyroid Autoantibody

BAYER DIAGNOSTICS CORP.

The following data is part of a premarket notification filed by Bayer Diagnostics Corp. with the FDA for Bayer Diagnostics Acs:180 And Advia Centaur Anti-tpo Assay.

Pre-market Notification Details

Device IDK003291
510k NumberK003291
Device Name:BAYER DIAGNOSTICS ACS:180 AND ADVIA CENTAUR ANTI-TPO ASSAY
ClassificationSystem, Test, Thyroid Autoantibody
Applicant BAYER DIAGNOSTICS CORP. 63 NORTH ST. Medfield,  MA  02052
ContactWilliam J Pignato
CorrespondentWilliam J Pignato
BAYER DIAGNOSTICS CORP. 63 NORTH ST. Medfield,  MA  02052
Product CodeJZO  
CFR Regulation Number866.5870 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2000-10-20
Decision Date2000-12-05

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00630414973920 K003291 000
00630414587837 K003291 000
00630414587844 K003291 000
00630414587912 K003291 000
00630414587936 K003291 000
00630414588476 K003291 000
00630414597935 K003291 000
00630414597942 K003291 000
00630414597959 K003291 000
00630414597966 K003291 000
00630414597973 K003291 000
00630414598437 K003291 000
00630414457352 K003291 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.